Patent · US Active

Naphthyridine derivatives and the use thereof as kinase inhibitors

US8461178B2 · kind B2 · utility

0Cited by

2References

9Claims

0Family size

Assignee

Aeterna Zentaris, Inc. · DE

Inventors

Tilmann Schuster · Großostheim, DE
Matthias Gerlach · Wächtersbach, DE
Irene Seipelt · Offenbach, DE
Emmanuel Polymeropoulos · Frankfurt, DE
Gilbert Mueller · Frankfurt am Main, DE
Eckhard Guenther · Maintal, DE
Pascal Marchand · Nantes, FR
Julien Defaux · Dijon, FR

Key dates

Filing date	Nov 24, 2010
Grant date	Jun 11, 2013
Priority date	—
Expiry date	Oct 11, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to kinase modulators of the naphthyridine type and to the preparation and use thereof as medicaments for the modulation of misdirected cellular signal transduction processes, in particular for influencing the function of tyrosine and serine/threonine kinases and for the treatment of malignant or benign tumors and other disorders based on pathological cell proliferation, such as, for example, restenosis, psoriasis, arteriosclerosis and cirrhosis of the liver.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.